Gene signature predicted spread of brain metastases in HER-2–positive patients, HemOnc Today, July 10, 2012
Correlation Between Quantitative HER-2 Protein Expression and Risk for Brain Metastases in HER-2+ Advanced Breast Cancer Patients Receiving Trastuzumab-Containing Therapy. The oncologist 2012 Jan 10; 17(1):26-35
Praca naszych lekarzy nagrodzona podczas największego kongresu onkologicznego na świecie, Military Institute of Medicine, 25.07.2008
Medical University of GdańskDepartment ofOncology and Radiotherapy17 Smoluchowskiego St80-214 Gdańsk, Poland
© Polish Brain Metastasis Consortium
Privacy Policy
We use cookies and similar technologies to improve your experience on our website.
This website uses cookies and similar technologies. They are grouped into categories, which you can review and manage below. If you have accepted any non-essential cookies, you can change your preferences at any time in the settings.
These technologies are required to activate the core functionality of our website.
These technologies allow our website to remember your preferences and provide you with a more personalized experience.